Related Experiment Video
Updated: May 22, 2026

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin
Natasha E Holmes1, Paul D R Johnson, Benjamin P Howden
1Austin Centre for Infection Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, USA.
Abstract:
Vancomycin has been used successfully for over 50 years for the treatment of Staphylococcus aureus infections, particularly those involving methicillin-resistant S. aureus. It has proven remarkably reliable, but its efficacy is now being questioned with the emergence of strains of S. aureus that display heteroresistance, intermediate resistance, and, occasionally, complete vancomycin resistance. More recently, an association has been established between poor outcome and infections with strains of S. aureus with an elevated vancomycin MIC within the susceptible range. This minireview summarizes the definitions, mechanisms, clinical impact, and laboratory identification of reduced vancomycin susceptibility in S. aureus and discusses practical issues for the diagnostic laboratory in testing and interpreting vancomycin susceptibility for S. aureus infections.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Estimation of k and VD of Aminoglycosides
Antimicrobial Effectiveness

